Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.02, 9.01 · 8-K

Adia Med, Inc.

ADIAOTCEQUITYCurrent

Termination of a Material Definitive Agreement

Item 1.02. Termination of a Material Definitive Agreement On October 9, 2026, Adia Med, Inc. (the “Company”) fully repaid and discharged its unsecured revolving line of credit facility originally entered into on June 30, 2024, between Larry Powalisz, Chief Executive Officer of the Company, as lender (the “Lender”), and the Company (and its relevant subsidiaries, as applicable), as borrower.…

Filed Oct 13, 2026Accepted Oct 13, 2026, 7:46 AM EDTCIK 1160420Accession 0001683168-26-007770
Share

Company context

Current securities

Recent company filings

  1. 10-Q filingNov 16, 2026
  2. Entry into a Material Definitive AgreementOct 19, 2026
  3. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of AssetsOct 6, 2026
  4. Other EventsOct 5, 2026
  5. Entry into a Material Definitive AgreementAug 24, 2026

Registered securities in this filing

ADIA MED, INC. · 8-K · Filed 2026-10-13

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common A Stock, par value $0.001 per share

Symbol
Not supplied
Exchange
Not supplied
Classification
COMMON
Filing context

Context: AsOf2026-10-09

Dimensions: Not supplied

Accession 000168316826007770 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.02Item 1.02 - Termination of Material Agreement
Item 1.02. Termination of a Material Definitive Agreement On October 9, 2026, Adia Med, Inc. (the “Company”) fully repaid and discharged its unsecured revolving line of credit facility originally entered into on June 30, 2024, between Larry Powalisz, Chief Executive Officer of the Company, as lender (the “Lender”), and the Company (and its relevant subsidiaries, as applicable), as borrower. The Facility had been increased over time to a commitment of $1,000,000 by the Lender, to best accommodate the growth needs of the Company, and bore interest at 6% per annum calculated daily. In satisfaction of the obligation to the Lender, the Company made the following payments to the Lender: October 7, 2026: $500,000; October 9, 2026: $434,970.94 (of which $74,658.94 constituted accrued interest, and the balance applied to principal). Total amount paid to the Lender was $934,970.94. The Lender has acknowledged that the outstanding principal balance and all accrued interest under the Facility have been paid in full as of October 9, 2026. As a result, the Facility is satisfied in full, with respect to all amounts owing through that date. The Lender, a related party, is the Chief Executive Officer of the Company. The foregoing facility is satisfied and discharged and qualified in its entirety by reference to the full text of the Paid-in-Full Acknowledgment dated October 9, 2026, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.